Vida Ventures — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Praxis Precision MedicinesNASDAQ: PRAXJun 2019SEC filingmedium confidence
Therapeutic company focused on validated targets for treating neurological and psychiatric disorders.
BiotechCambridge, US
Kiran Reddy(Executive Officer, Director)
BoardNicholas G. Galakatos(Director)
Board seatStefan Vitorovic· per SEC Form D · $10M raise · filed Jun 2019
Co-investorsOCV PartnersClarus
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.